Sequential ascending multiple-dose safety and pharmacokinetic study of oral lobucavir (BMS-180194) in asymptomatic volunteers seropositive for HIV and CMV: BG Petty, M Wachsman, MC Jordan, H Burgee, D DeHertogh, D Collins, RS Summerill, DA Jabs, JP Dunn, N Hellmann, B Kringstad, C Fletcher, L Smaldone, PS Lietman, MB Stewart. Division of Clinical Pharmacology, The Johns Hopkins University School of Medicine, Baltimore, MD; University of Minnesota, Minneapolis, MN; and Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ and Wallingford, CT, USA